Developing an Automated HIV Self-Test for Use in Developing Countries
Principal investigator discusses a new research initiative to create a low-cost, rapid HIV self-test.
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Subscribe today for access to
Articles and Reports
Latest Articles
AI Combined with DM and ABUS Can Improve Breast Cancer Detection
Researchers found that combining AI with both imaging technologies can improve the detection of cancer in women with dense breasts.
New Breakthrough Device Designations Fall 37 Percent in 2022
According to the FDA’s recently-released annual report, only 135 devices received the designation last year, versus 213 in 2021.
New Urine Test Can Detect Synthetic Cannabinoids in Marijuana
Recent study shows the new test can identify a widespread and dangerous class of synthetic cannabinoids called BZO-CHMOXIZID.
New Study Supports Accuracy of Diagnoses from Video Visits
Video telehealth during the early period of the COVID-19 quarantine was actually highly effective in providing accurate diagnoses, research shows.
Polygenic Risk Scores Can Predict Chance of Sudden Cardiac Death
Recent study shows scores capable of assessing genetic risk of coronary artery disease can also ID those at high risk of death.
November 2022 FDA Watch: Pace of New Approvals Slows
Though there were fewer new approvals last month, the impact of the products that did gain approval more than made up for the drop in volume.
Abbott Ushers Monkeypox Testing into Its New Commercial Phase
Abbott has once more gotten the jump by becoming the first company to get EUA clearance for a commercial monkeypox RT-PCR test kit.
CMS to Create New Breakthrough Device Medicare Coverage Rule
The rule would ensure Medicare coverage of newly approved breakthrough devices, but have stricter evidence standards.
Blood Test Can Reliably Predict Patient Risk of Long COVID
Research offers new evidence that a test targeting blood-based biomarkers can predict someone’s risk of developing long COVID.
Pharmacogenetic Testing Leads to Better Depression Treatment Decisions
A recent study shows pharmacogenetic testing can help caregivers make better decisions when prescribing antidepressants.
New Guideline for Using Lab Tests to Improve Cancer Treatment
The new CAP guidance addresses use of immune checkpoint inhibitors for evaluating and treating patients with specific cancers.
New Joint Commission Health Equity Standard Takes Effect Jan. 1
What the equity rule is, who it affects, and how to comply.
